caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548256241

Deborah Remy ParrPA C

PRACTICEUIHC UROLOGY CLINICSee all providers at this practice →
Physician AssistantIowa City, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Deborah Remy Parr's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
STATE UNIVERSITY OF IOWA130515
Michele Freesmeier
Physician Assistant · Iowa City, IA
1829
Alexandra Thomas
Hematology-Oncology · Winston Salem, NC
14139
Michael Graham
Nuclear Medicine · Iowa City, IA
1318
Maheen Rajput
Diagnostic Radiology · Iowa City, IA
1316
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
132
Unique beneficiaries
—
Total services
243
Distinct HCPCS
3
Medicare payment
$11K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,050 Physician Assistant providers in IA — below median (cohort median 356).
PRESCRIBING · PART D · 2024
Total Rx claims
170
Beneficiaries
—
Total drug cost
$49K
Distinct drugs
6
Brand share
8.2%
Top prescribed drugs
Imatinib Mesylate91 claims
Ondansetron Hcl21 claims
Oxycodone Hcl17 claims
Gabapentin14 claims
Morphine Sulfate14 claims
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
75.7
Cost
72.3
Improvement activities
40.0
Promoting interop.
78.0
Payment adjustment
0.21%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.